Testified at a hearing before the U.S. House of Representatives' Committee on Ways and Means as a neutral ERISA pundit regarding Appropriateness of 401(k) Fees
This event has already occurred.
Related Insights
Federal Circuit Interprets IPR Estoppel Under 35 U.S.C. § 315(e)(2) to Permit at Trial Invalidity Theories Based on Prior Use or Sale